lamivudine 150 MG / zidovudine 300 MG Oral Tablet
- RxCUI
- 200082
- RxNorm name
- lamivudine 150 MG / zidovudine 300 MG Oral Tablet
- Display name
- lamivudine 150 MG / zidovudine 300 MG Oral Tablet
- Full name
- lamivudine 150 MG / zidovudine 300 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lamivudine and Zidovudine | LAMIVUDINE AND ZIDOVUDINE | Camber Pharmaceuticals, Inc. | e816e8f5-1e50-4f49-8bea-92da0121d26e | 2026-03-12 | Boxed warning, Warnings, Adverse reactions | 200082 |
| LAMIVUDINE and ZIDOVUDINE | LAMIVUDINE AND ZIDOVUDINE | PD-Rx Pharmaceuticals, Inc. | ff62c5fc-965d-4534-a571-a4f290cb9d83 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | 200082 |
| Lamivudine and Zidovudine | LAMIVUDINE AND ZIDOVUDINE | Aurobindo Pharma Limited | d40292ff-046c-4a04-b801-10768667951a | 2024-05-24 | Boxed warning, Warnings, Adverse reactions | 200082 |
| Lamivudine and Zidovudine | LAMIVUDINE AND ZIDOVUDINE | Bryant Ranch Prepack | 61d14a88-9fdf-4373-8360-44ec9e1cd350 | 2024-04-05 | Boxed warning, Warnings, Adverse reactions | 200082 |
| COMBIVIR | LAMIVUDINE AND ZIDOVUDINE | ViiV Healthcare Company | 16da660b-9981-4d24-a14a-94c7744fce4f | 2023-08-22 | Boxed warning, Warnings, Adverse reactions | 200082 |
| Lamivudine and Zidovudine | LAMIVUDINE AND ZIDOVUDINE | Macleods Pharmaceuticals Limited | 63667952-be01-483e-9887-1d5417e7ec16 | 2023-07-13 | Boxed warning, Warnings, Adverse reactions | 200082 |
| LAMIVUDINE and ZIDOVUDINE | LAMIVUDINE AND ZIDOVUDINE | Bryant Ranch Prepack | 005f1b9d-1950-4ef3-a9d6-c428a40a3630 | 2023-03-29 | Boxed warning, Warnings, Adverse reactions | 200082 |
| LAMIVUDINE AND ZIDOVUDINE | LAMIVUDINE AND ZIDOVUDINE | XLCare Pharmaceuticals, Inc | 55520835-0f24-4e52-af8c-d65841ccaba7 | 2023-01-16 | Boxed warning, Warnings, Adverse reactions | 200082 |
| LAMIVUDINE and ZIDOVUDINE | LAMIVUDINE AND ZIDOVUDINE | Camber Pharmaceuticals, Inc. | f80bd0f3-47eb-4b82-a633-4536cf376cf6 | 2022-09-16 | Boxed warning, Warnings, Adverse reactions | 200082 |
| Lamivudine and Zidovudine | LAMIVUDINE AND ZIDOVUDINE | Exelan Pharmaceuticals Inc. | 4cf565c3-bdec-4c18-93c1-cc7fa8331c90 | 2019-01-01 | Boxed warning, Warnings, Adverse reactions | 200082 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 61d14a88-9fdf-4373-8360-44ec9e1cd350 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 102 | These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | 20240405 |
| 16da660b-9981-4d24-a14a-94c7744fce4f | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 22 | These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine tablets), for oral use Initial U.S. Approval: 1997 | 20230822 |
| ff62c5fc-965d-4534-a571-a4f290cb9d83 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 13 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets , for oral use Initial U.S. Approval: 1997 | 20251017 |
| e816e8f5-1e50-4f49-8bea-92da0121d26e | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 7 | These highlights do not include all the information needed to use LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE AND ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | 20260312 |
| f80bd0f3-47eb-4b82-a633-4536cf376cf6 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 7 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets , for oral use Initial U.S. Approval: 1997 | 20220916 |
| d40292ff-046c-4a04-b801-10768667951a | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 6 | These highlights do not include all the information needed to use LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE AND ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | 20240524 |
| 005f1b9d-1950-4ef3-a9d6-c428a40a3630 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 5 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets USP, for oral use Initial U.S. Approval: 1997 | 20230329 |
| 63667952-be01-483e-9887-1d5417e7ec16 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 4 | These highlights do not include all the information needed to use LAMIVUDINE and ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE and ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | 20230713 |
| 55520835-0f24-4e52-af8c-d65841ccaba7 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for LAMIVUDINE AND ZIDOVUDINE TABLETS. LAMIVUDINE and ZIDOVUDINE tablets, for oral use Initial U.S. Approval: 1997 | 20230116 |
| 4cf565c3-bdec-4c18-93c1-cc7fa8331c90 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use lamivudine and zidovudine safely and effectively. See full prescribing information for lamivudine and zidovudine. Lamivudine and Zidovudine Tablets, USP Initial U.S. Approval: 1997 | 20190101 |
| 97f25ee5-aa70-4f7a-b710-50b56e5de135 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use lamivudine and zidovudine tablets safely and effectively. See full prescribing information for lamivudine and zidovudine tablets. lamivudine and zidovudine tablets Initial U.S. Approval: 1997 | 20180518 |
| 77eccfa0-c03c-49a3-bfa7-f31888d77161 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 2 | Lamivudine Zidovudine | 20160622 |
| 1bc4c6c8-7e75-494e-810b-8f83135a3204 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997 | 20140227 |
| fc2d6065-7806-457c-82e1-04bb19e57b8c | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP. LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997 | 20120625 |
| d346d08d-ebb5-4500-923f-fe111f304876 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use lamivudine and zidovudine tablets USP safely and effectively. See full prescribing information for lamivudine and zidovudine tablets USP. LAMIVUDINE and ZIDOVUDINE tablets, USP 150 mg/300 mg for oral use Initial U.S. Approval: 1997 | 20120404 |
| 479a2784-8db2-4fe5-94ba-55316a3c4e4f | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997 | 20120202 |
| d8540843-055c-47fb-9cff-81e64b1d41c3 | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use COMBIVIR safely and effectively. See full prescribing information for COMBIVIR. COMBIVIR (lamivudine and zidovudine) Tablets 150 mg/300 mg Initial U.S. Approval: 1997 | 20100924 |
| b03e286a-4d44-489a-89d0-ee563e1f280f | lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [PSN] · lamivudine 150 MG / zidovudine 300 MG Oral Tablet [SCD] · 3TC 150 MG / AZT 300 MG Oral Tablet [SY] | 3 | 1 | COMBIVIR (lamivudine and zidovudine) tablet, film coated | 20091027 |